FDA Catalyst Calendar
The FDA Catalyst Calendar is a chronological calendar of biotech events that could move the stock price. These include clinical trials, commercial, and FDA or other regulatory events.
Specifically these events include FDA PDUFA/Approval dates, FDA Advisory Committee meetings, Ph 1-3 initiation, updates, and readouts. We also include some other events pertaining to EU regulatory, patent, and revenue/commercial events. Learn more about the FDA Catalyst Calendar with these FAQ's here.
This version is limited to 50 results and no search features, to use the full search and see all results create a free account.
Catalyst Date Range
Drug | Disease (links)
Stage (next event)
FDA Catalyst Calendar FAQ
What events are listed on the FDA Catalyst Calendar?
The FDA Catalyst Calendar lists all upcoming events including:
FDA PDUFA / approval decisions.
FDA and regulatory filings (NDA, BLA).
Phase 1-3 clinical trial initiation, updates, and readouts.
Readouts at major biotech medical conferences.
Where are the catalyst dates sourced from?
All dates are manually sourced from company press releases, FDA / regulatory sites, or medical conferences.
What companies are included?
We have assets for over 550 micro to mid cap biotech companies.
These companies range in market cap from $100M to ~$10B.
If you are a Pro member we will add any ticker or asset within our range for you.
This FDA Catalyst Calendar version is limited to 50 results and no search features, to use the full FDA Catalyst Calendar which includes: unlimited search and displays all results create a free account.